FDA QMSR Transition Training Course

ISO 13485 is an international quality management system standard for medical devices, while 21 CFR Part 820 is the FDA regulation governing device quality systems in the United States. They overlap in areas such as document control, CAPA, and design controls, but they differ in regulatory context and wording. FDA’s QMSR is intended to align its framework more closely with ISO 13485.

The timeline varies with the maturity and scope of your quality management system. Organizations with established processes may spend several months completing a gap assessment, implementing controls, conducting internal audits, holding management review, and preparing for a certification audit. New systems often require longer. Training can accelerate readiness by helping personnel consistently apply ISO 13485 requirements and maintain the evidence auditors need.

The FDA Quality Management System Regulation, or QMSR, is the agency’s modernization of medical device quality system requirements. It replaces the former Quality System Regulation framework in 21 CFR Part 820 and incorporates ISO 13485:2016 by reference, with FDA-specific provisions. Device manufacturers need to understand how their existing procedures, records, supplier controls, and audit preparation practices align with the updated regulation.

This training is designed for medical device QMS managers, regulatory affairs professionals, quality engineers, internal auditors, CAPA owners, document-control personnel, and leaders responsible for inspection readiness. Cross-functional stakeholders involved in design, manufacturing, supplier quality, complaint handling, or post-market activities also benefit. A shared understanding helps teams apply requirements consistently rather than relying on one compliance specialist.

The Medical Device & Life Sciences QMS Training Pathway bundles ISO 13485 Medical Device QMS, FDA 21 CFR Part 820, ISO 14971 Risk Management, and HIPAA Privacy & Security topics. It addresses design controls, document control, CAPA, management review, internal audits, inspection readiness, Form 483 response, risk controls, post-market risk-file maintenance, and privacy obligations for connected devices, software, and integrations.

The FDA 21 CFR Part 820 Course is planned as a self-paced pilot cohort opening in Q3 2026. It includes a subpart-by-subpart Quality System Regulation deep dive, inspection-readiness content, Form 483 response guidance, and the FDA Quality System Inspection Technique approach. Organizations can book a 30-minute demo to discuss the pilot cohort, pathway pricing, and team learning needs.

The QMS Workbench is trained on ISO 13485:2016, FDA 21 CFR Part 820, ISO 14971:2019, the ISO 14971:2020 amendment, and FDA Quality System Inspection Technique materials. It supports practical work by helping learners draft design history file entries, build risk-management plans, and generate CAPA records. The goal is to pair learning with guided application and auditable artifacts.

Yes. QMS Learning includes a Manager Dashboard that provides visibility into learner progress, capability gaps, and exam outcomes. Teams can also create an Audit-Evidence Package export containing training records, completed scenarios, AI-generated artifacts, and time-stamped activity. This gives quality leaders a more organized way to demonstrate training and competency evidence during internal, customer, or regulatory audits.